Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 2 · 100%High 0 · 0%

Intravitreal dexamethasone implant 0.7 mg vs antiVEGF

Cataract progression · macular edema in diabetes

Intravitreal dexamethasone implant 0.7 mg probably leads to higher cataract progression ‐ 12 to 24 months compared with intravitreal antiVEGF (moderate certainty).

1 finding from 1 review

Intravitreal steroids for macular edema in diabetes 2020 · Cochrane Headline outcomes only
RR 4.23 [2.36, 7.59]
Studies not reported
Moderate

Intravitreal dexamethasone implant 0.7 mg vs sham

Cataract progression · macular edema in diabetes

Intravitreal dexamethasone implant 0.7 mg probably leads to higher cataract progression ‐ 36 months compared with sham (moderate certainty).

1 finding from 1 review

Intravitreal steroids for macular edema in diabetes 2020 · Cochrane Headline outcomes only
RR 3.89 [2.75, 5.5]
1 study · 697 participants
Moderate